Company intelligence / Profile preview
Multi-Apex Pharma
- Ownership
- Private
- Development stage
- Commercial
Overview
Multi-Apex Pharma is a leading Egyptian pharmaceutical manufacturer established in 1997. The company produces a wide range of high-quality generic medicines across most major therapeutic areas for the Egyptian market and MENA region. It operates state-of-the-art GMP-certified facilities in Badr City near Cairo. The company has not disclosed specific clinical trial results but maintains ISO certifications for quality management systems. It has also announced plans to expand manufacturing into Saudi Arabia with local partners.
- Therapeutic areas
- OtherDermatologyRheumatologyCardiovascularNeurologyWomen's Health
- Modalities
- Small molecules
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Multi-Apex Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Multi-Apex Pharma.